Your browser doesn't support javascript.
loading
Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic.
McLaughlin, Patricia J; Odom, Laura B; Arnett, Peter A; Orehek, Shannon; Thomas, Gary A; Zagon, Ian S.
  • McLaughlin PJ; Department of Neural and Behavioral Sciences, Pennsylvania State University College of Medicine, Hershey, PA, United States.
  • Odom LB; Department of Neural and Behavioral Sciences, Pennsylvania State University College of Medicine, Hershey, PA, United States.
  • Arnett PA; Department of Psychology, Pennsylvania State University, University Park, PA, United States.
  • Orehek S; Department of Neurology, Milton S. Hershey Medical Center, Penn State Health, Hershey, PA, United States.
  • Thomas GA; Department of Neurology, Milton S. Hershey Medical Center, Penn State Health, Hershey, PA, United States.
  • Zagon IS; Department of Neural and Behavioral Sciences, Pennsylvania State University College of Medicine, Hershey, PA, United States.
Int Immunopharmacol ; 113(Pt B): 109438, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36379151
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article